429 related articles for article (PubMed ID: 34084175)
1. Canonical Secretomes, Innate Immune Caspase-1-, 4/11-Gasdermin D Non-Canonical Secretomes and Exosomes May Contribute to Maintain Treg-Ness for Treg Immunosuppression, Tissue Repair and Modulate Anti-Tumor Immunity
Ni D; Tang T; Lu Y; Xu K; Shao Y; Saaoud F; Saredy J; Liu L; Drummer C; Sun Y; Hu W; Lopez-Pastrana J; Luo JJ; Jiang X; Choi ET; Wang H; Yang X
Front Immunol; 2021; 12():678201. PubMed ID: 34084175
[TBL] [Abstract][Full Text] [Related]
2. Aorta in Pathologies May Function as an Immune Organ by Upregulating Secretomes for Immune and Vascular Cell Activation, Differentiation and Trans-Differentiation-Early Secretomes may Serve as Drivers for Trained Immunity.
Lu Y; Sun Y; Xu K; Saaoud F; Shao Y; Drummer C; Wu S; Hu W; Yu J; Kunapuli SP; Bethea JR; Vazquez-Padron RI; Sun J; Jiang X; Wang H; Yang X
Front Immunol; 2022; 13():858256. PubMed ID: 35320939
[TBL] [Abstract][Full Text] [Related]
3. Tissue Treg Secretomes and Transcription Factors Shared With Stem Cells Contribute to a Treg Niche to Maintain Treg-Ness With 80% Innate Immune Pathways, and Functions of Immunosuppression and Tissue Repair.
Zhang R; Xu K; Shao Y; Sun Y; Saredy J; Cutler E; Yao T; Liu M; Liu L; Drummer Iv C; Lu Y; Saaoud F; Ni D; Wang J; Li Y; Li R; Jiang X; Wang H; Yang X
Front Immunol; 2020; 11():632239. PubMed ID: 33613572
[TBL] [Abstract][Full Text] [Related]
4. Novel Knowledge-Based Transcriptomic Profiling of Lipid Lysophosphatidylinositol-Induced Endothelial Cell Activation.
Xu K; Shao Y; Saaoud F; Gillespie A; Drummer C; Liu L; Lu Y; Sun Y; Xi H; Tükel Ç; Pratico D; Qin X; Sun J; Choi ET; Jiang X; Wang H; Yang X
Front Cardiovasc Med; 2021; 8():773473. PubMed ID: 34912867
[TBL] [Abstract][Full Text] [Related]
5. Single-Cell Sequencing Reveals the Transcriptome and TCR Characteristics of pTregs and
Hui Z; Zhang J; Zheng Y; Yang L; Yu W; An Y; Wei F; Ren X
Front Immunol; 2021; 12():619932. PubMed ID: 33868236
[TBL] [Abstract][Full Text] [Related]
6. Treg-mediated acquired resistance to immune checkpoint inhibitors.
Saleh R; Elkord E
Cancer Lett; 2019 Aug; 457():168-179. PubMed ID: 31078738
[TBL] [Abstract][Full Text] [Related]
7. FoxP3
Saleh R; Elkord E
Cancer Lett; 2020 Oct; 490():174-185. PubMed ID: 32721551
[TBL] [Abstract][Full Text] [Related]
8. Immunometabolic Checkpoints of Treg Dynamics: Adaptation to Microenvironmental Opportunities and Challenges.
Pacella I; Piconese S
Front Immunol; 2019; 10():1889. PubMed ID: 31507585
[TBL] [Abstract][Full Text] [Related]
9. Treg-expressed CTLA-4 depletes CD80/CD86 by trogocytosis, releasing free PD-L1 on antigen-presenting cells.
Tekguc M; Wing JB; Osaki M; Long J; Sakaguchi S
Proc Natl Acad Sci U S A; 2021 Jul; 118(30):. PubMed ID: 34301886
[TBL] [Abstract][Full Text] [Related]
10. A tumor-specific mechanism of T
Seed RI; Kobayashi K; Ito S; Takasaka N; Cormier A; Jespersen JM; Publicover J; Trilok S; Combes AJ; Chew NW; Chapman J; Krummel MF; Lou J; Marks J; Cheng Y; Baron JL; Nishimura SL
Sci Immunol; 2021 Mar; 6(57):. PubMed ID: 33771888
[TBL] [Abstract][Full Text] [Related]
11. Human Tregs at the materno-fetal interface show site-specific adaptation reminiscent of tumor Tregs.
Wienke J; Brouwers L; van der Burg LM; Mokry M; Scholman RC; Nikkels PG; van Rijn BB; van Wijk F
JCI Insight; 2020 Sep; 5(18):. PubMed ID: 32809975
[TBL] [Abstract][Full Text] [Related]
12. GITR Blockade Facilitates Treg Mediated Allograft Survival.
Sonawane SB; Kim JI; Lee MK; Lee SH; Duff PE; Moore DJ; Lian MM; Deng S; Choi Y; Yeh H; Caton AJ; Markmann JF
Transplantation; 2009 Nov; 88(10):1169-77. PubMed ID: 19935370
[TBL] [Abstract][Full Text] [Related]
13. A GMCSF-Neuroantigen Tolerogenic Vaccine Elicits Systemic Lymphocytosis of CD4
Moorman CD; Curtis AD; Bastian AG; Elliott SE; Mannie MD
Front Immunol; 2018; 9():3119. PubMed ID: 30687323
[TBL] [Abstract][Full Text] [Related]
14. Direct targeting of FOXP3 in Tregs with AZD8701, a novel antisense oligonucleotide to relieve immunosuppression in cancer.
Revenko A; Carnevalli LS; Sinclair C; Johnson B; Peter A; Taylor M; Hettrick L; Chapman M; Klein S; Solanki A; Gattis D; Watt A; Hughes AM; Magiera L; Kar G; Ireland L; Mele DA; Sah V; Singh M; Walton J; Mairesse M; King M; Edbrooke M; Lyne P; Barry ST; Fawell S; Goldberg FW; MacLeod AR
J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35387780
[TBL] [Abstract][Full Text] [Related]
15. Cancer immunotherapy with check point inhibitor can cause autoimmune adverse events due to loss of Treg homeostasis.
Kumar P; Saini S; Prabhakar BS
Semin Cancer Biol; 2020 Aug; 64():29-35. PubMed ID: 30716481
[TBL] [Abstract][Full Text] [Related]
16. Emerging Functions of Regulatory T Cells in Tissue Homeostasis.
Sharma A; Rudra D
Front Immunol; 2018; 9():883. PubMed ID: 29887862
[TBL] [Abstract][Full Text] [Related]
17. Correlations between Circulating and Tumor-Infiltrating CD4
Al-Mterin MA; Murshed K; Elkord E
Vaccines (Basel); 2022 Mar; 10(4):. PubMed ID: 35455287
[TBL] [Abstract][Full Text] [Related]
18. Treg-dependent immunosuppression triggers effector T cell dysfunction via the STING/ILC2 axis.
Domvri K; Petanidis S; Zarogoulidis P; Anestakis D; Tsavlis D; Bai C; Huang H; Freitag L; Hohenforst-Schmidt W; Porpodis K; Katopodi T
Clin Immunol; 2021 Jan; 222():108620. PubMed ID: 33176208
[TBL] [Abstract][Full Text] [Related]
19. Regulatory T cells as therapeutic targets and mediators.
Sharma A; Rudra D
Int Rev Immunol; 2019; 38(5):183-203. PubMed ID: 31154878
[TBL] [Abstract][Full Text] [Related]
20. Effect of Regulatory T Cells on Promoting Apoptosis of T Lymphocyte and Its Regulatory Mechanism in Sepsis.
Luan YY; Yin CF; Qin QH; Dong N; Zhu XM; Sheng ZY; Zhang QH; Yao YM
J Interferon Cytokine Res; 2015 Dec; 35(12):969-80. PubMed ID: 26309018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
